In a study published in Cancer Research, BCRF researchers Drs. Jill Bargonetti and Funmi Olopade report a possible new treatment strategy that targets vulnerabilities in triple-negative breast cancer (TNBC), a particularly aggressive form of the disease with limited treatment options.